Health-related quality of life in different states of breast cancer – comparing different instruments

References

• Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr
   Google Scholar
• Finnish Cancer Registry, Cancer Statistics; [cited 2016 Mar 5]. Available from: www.cancerregistry.fi
   Google Scholar
• Engholm G, Ferlay J, Christensen N, et al. NORDCAN—a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 2010;49:725–736.
   PubMed Web of Science ®Google Scholar
• Engholm G, Ferlay J, Christensen N, et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 7.1 (09.07.2015). Finland: Association of the Nordic Cancer Registries. Danish Cancer Society; [cited 2015 Sep 12]. Available from: http://www.ancr.nu
   Google Scholar
• Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–1241.
   PubMed Web of Science ®Google Scholar
• Meretoja TM, Svarvar C, Jahkola TA. Outcome of oncoplastic breast surgery in 90 prospective patients. Am J Surg. 2010;200:224–228.
   PubMed Web of Science ®Google Scholar
• Chakravorty A, Shrestha AK, Sanmugalingam N, et al. How safe is oncoplastic breast conservation? Comparative analysis with standard breast conserving surgery. Eur J Surg Oncol. 2012;38:395–398.
   PubMed Web of Science ®Google Scholar
• von Smitten K. Margin status after breast-conserving treatment of breast cancer: how much free margin is enough? J Surg Oncol. 2008;98:585–587.
   PubMed Web of Science ®Google Scholar
• Editorial. Quality of life and clinical trials. Lancet. 1995;346:1–2.
   Web of Science ®Google Scholar
• Glaser AW, Fraser LK, Corner J, et al. Patient-reported outcomes of cancer survivors in England 1–5 years after diagnosis: a cross-sectional survey. BMJ Open. 2013;3:e002317.
   PubMed Web of Science ®Google Scholar
• Carr AJ, Gibson B, Robinson PG. Measuring quality of life: is quality of life determined by expectations or experience? BMJ. 2001;322:1240–1243.
   PubMed Web of Science ®Google Scholar
• Brooks R, with the EuroQol Group. EuroQol: the current state of play. Health Policy. 1996;37:53–72.
   PubMed Web of Science ®Google Scholar
• Chopra I, Kamal KM. A systematic review of quality of life instruments in long-term cancer survivors. Health Qual Life Outcomes. 2012;10:14.
   PubMed Web of Science ®Google Scholar
• Crott R, Versteegh M, Uyl-de-Groot C. An assessment of the external validity of mapping QLQ-C30 to EQ-5D preferences. Qual Life Res. 2013;22:1045–1054.
   PubMed Web of Science ®Google Scholar
• Penttinen H, Rautalin M, Roine R, et al. Quality of life of recently treated patients with breast cancer. Anticancer Res. 2014;34:1201–1206.
   PubMed Web of Science ®Google Scholar
• Färkkilä N, Torvinen S, Roine RP, et al. Health-related quality of life among breast, prostate and colorectal patients with end-state disease. Qual Life Res. 2014;23:1387–1394.
   PubMed Web of Science ®Google Scholar
• Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med. 2001;33:328–336.
   PubMed Web of Science ®Google Scholar
• The EORTC Quality of Life Group & EORTC Quality of Life Unit. Guidelines for assessing quality of life in EORTC Clinical Trials. Brussels: EORTC Data Center; 2002. ISBN 2-930064-27-7.
   Google Scholar
• EuroQoL Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.
   PubMed Web of Science ®Google Scholar
• Alanne S, Roine RP, Rasanen P, et al. Estimating the minimum important change in the 15D scores. Qual Life Res. 2015;24:599–606.
   PubMed Web of Science ®Google Scholar
• Pickard AS, Neary MP, Cella D. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes. 2007;5:70.
   PubMed Web of Science ®Google Scholar
• Hoyer M, Johansson B, Nordin K, et al. Health-related quality of life among women with breast cancer – a population-based study. Acta Oncol. 2011;50:1015–1026.
   PubMed Web of Science ®Google Scholar
• Campbell-Enns H, Woodgate R. The psychosocial experiences of women with breast cancer across the lifespan: a systematic review protocol. JBI Database Syst Rev Implement Rep. 2015;13:112–121.
   PubMedGoogle Scholar
• Penttinen HM, Saarto T, Kellokumpu-Lehtinen P, et al. Quality of life and physical performance and activity of breast cancer patients after adjuvant treatments. Psycho-Oncology. 2011;20:1211–1220.
   PubMed Web of Science ®Google Scholar
• Kokkonen K, Saarto T, Mäkinen T, et al. The functional capacity and quality of life of women with advanced breast cancer. Breast Cancer. 2017;24:128–136.
   PubMed Web of Science ®Google Scholar
• Roine E, Blomqvist C, Kellokumpu-Lehtinen PL, et al. Health-related quality of life in breast cancer patients after adjuvant treatments. Breast J. 2016;22:473–475.
   PubMed Web of Science ®Google Scholar